Purpose: Lamotrigine (LTG) is a broad-spectrum antiepileptic drug that is widely used in clinic. However, the effect of LTG on cognition and neurodegeneration during epilepsy treatment remains controversial. In this study, we compared the cognitive effects of LTG and sodium valproate in pentylenetetrazole (PTZ)-kindled animal model, and the dose dependency was tested for LTG.
& Kan, 2012) . The purpose of the current study was to compare the effect of different doses of LTG with VPA on cognitive impairment and hippocampal neuronal damage induced by PTZ kindling.
| MATERIALS A ND METHODS

| Drugs and chemicals
PTZ was purchased from Sigma (St. Louis, MO, USA). Sodium valproate was obtained from Chengdu Ai Keda Chemical Technology Co., Ltd.
(China). LTG was received as a gift sample from GlaxoSmithKline (China) Investment Co., Ltd.
| Animals
All experiments used age-matched, sexually mature (2-3 month old) female Sprague-Dawley rats, which were obtained from Hebei Medical University 
| Induction of kindling
Induction of kindling was performed, as previously described (Xie, Wang, Mao, Qu, Luan, Jia, & Kan, 2012) . Briefly, 35 mg/kg of PTZ (dissolved in 0.9% sodium chloride) was injected intraperitoneally on alternate days, for a total of 13 injections for the kindling, and 0.9% sodium chloride was injected in the same way at a dose of 3.5 mL/kg in the sham group. Seizure stage was evaluated using Racine's scale (Racine, 1972; Xie, Wang, Mao, Qu, Luan, Jia, & Kan, 2012) after each PTZ injection. The kindling was considered to be successful when the animal's appearance reached stage 3 after two consecutive administrations.
| LTG and VPA treatment
At 48 hours after completion of the induction of kindling, the successfully kindled animals were randomly divided into six groups, and were intraperitoneally treated with LTG or VPA for two weeks following the protocol: control group, treated with 3.5 mL/kg of 0.9% sodium chloride daily; low-dose LTG group, treated with 12.5 mg/kg of LTG daily; middle-dose LTG group, treated with 25 mg/kg of LTG daily; high-dose LTG group, treated with 50 mg/kg of LTG daily; VPA group, treated with 300 mg/kg of VPA daily. Meanwhile, PTZ injection (35 mg/kg, i.p.) was continued on alternate days to keep the kindled station. Animals in the sham group were treated with 3.5 mL/kg of 0.9% sodium chloride in the same way, as described above.
| The morris water maze test
The Morris Water Maze (MWM) test started from the 10th day of treatment with LTG or VPA. The test took place in a tank with a diameter of 180 cm and a height of 70 cm. The tank was partially filled with 23 6 18C of water. A colorless escape platform was placed in the tank at a fixed location 1.5 cm below the water's surface. The tank was located in a quiet test room and was surrounded by black curtains with external cues visible from the water surface, allowing the rat to orientate itself in space. Four equal quadrants were marked out as entry points. Each rat completed five trials over five days, with four entries to the tank (randomized each day) per trial. For the first four days, rats were gently placed in the middle of the circulate edge in a randomly selected quadrant, with the nose toward the wall. After finding the platform, rats were allowed a thirty second rest period before starting the next entry. If rats failed to find the platform within 120 seconds, they were picked up and placed onto the platform to allow for a 30-second rest period; and their escape latency was recorded as 120 seconds. On the 5th day, a spatial probe test without a platform was assessed, and the number of times the rat went across the place where the platform had previously been located within 120 seconds were recorded (Morris, Garrud, Rawlins, & O'keefe, 1982; Xie, Wang, Mao, Qu, Luan, Jia, & Kan, 2012 ).
| Tissue processing
Brain tissues were harvested under deep anesthesia at 24 hours after the MWM test, and was kept in 4% paraformaldehyde overnight. The brain tissues were paraffin-embedded and sliced into 4-lm consecutive sections. The sections in the series throughout the entire hippocampus were used for TUNEL Staining.
| TUNEL staining
In order to determine the cell apoptosis of the hippocampus with different treatments after epilepsy, terminal deoxynucleotidyl transferasemediated dUTP nick end labeling (TUNEL) staining was carried out using an In situ Cell Death Detection Kit (Roche, USA), according to manufacturer's protocol. Briefly, after dewaxing and dehydration, the hippocampus tissue sections were incubated with proteinase K (20 lg/ mL), and washed with phosphate buffer saline. Then, the sections were incubated in the TUNEL reaction mixture, and visualized using a converter with a DAB substrate kit (ZSGB-BIO, Beijing, China). The sections were counter stained with hematoxylin, mounted onto slides, and covered with coverslips (Park, Kim, Chung, & Kim, 2013) .
| Evaluation of TUNEL staining
For the evaluation of TUNEL positive cells, immunohistochemical scores (IHSs) were used. Briefly, IHS is calculated by combining an estimate of the percentage of TUNEL positive cells (quantity score) with an estimate of the staining intensity (staining intensity score). The quantity score was estimated as follows: no staining is scored as 0, 1-10% of cells stained is scored as 1, 11-50% of cells stained is scored as 2, 51-80% of cells stained is scored as 3, and 81-100% of cells stained is scored as 4.
Staining intensity is rated on a scale of 0-3, where 0 5 negative; 1 5 weak; 2 5 moderate, and 3 5 strong. The raw data of IHSs were calculated by multiplying the quantity and staining intensity scores (Soslow, Dannenberg, Rush, Woerner, Khan, Masferrer, & Koki, 2000) .
| Statistical analysis
The statistical analysis was performed using SPSS software version 16.0. Data were analyzed by one-way ANOVA, followed by LSD post hoc test. All values are presented as mean 6 standard error of the mean (SEM), and statistical significance was considered at p < .05.
| R E S U L T S 3.1 | Seizure stage
The average seizure stage of rats significantly decreased in the LTG and VPA treated groups, compared to rats treated with vehicle in the control group (p < .05). Treatment with middle-dose and high-dose LTG significantly reduced the seizure stage of rats, compared to rats in the low-dose LTG treated group (p < .05, Figure 1 ).
| Morris water maze
No significant difference in escape latency was found on day one [F [5, 46] (Figure 2 ).
Significant changes in spatial probe was observed in different groups on day five of the MWM test [F [5, 46] 54.721, p 5 .001]. Spatial probe frequency was significantly improved in the middle-and highdose LTG and VPA treated groups, when compared to rats treated with vehicle in the control group (p < .05). However, treatment with low-dose LTG did not significantly improve spatial probe frequency, when compared to that in the control group (p > .05) (Figure 3 ).
| IHS of TUNEL staining in the hippocampal CA1 and CA3 region
A significant difference was observed in IHSs of TUNEL staining in the hippocampal CA1 region in different treatments [F [5,19] 53.522, p 5 .02], but not in the CA3 region [F [5, 19] 
| DISCUSSION
The study were took following the procedure as described above ( Figure 5) . The results presented above clearly established that middledose LTG (25 mg/kg/day) and high-dose LTG (50 mg/kg/day) had better effects on seizure control than low-dose LTG (12.5 mg/kg/day).
Escape latency and probe frequency improved in the middle-and highdose LTG treated groups. In addition, neuronal cell apoptosis in the hippocampal CA1 region was reduced in the middle-and high-dose LTG treated groups. However, there were no significant differences in seizure control, neuronal cell apoptosis of the hippocampal CA1 region and performance in the MWM test among the middle-dose LTG treatment group, high-dose LTG treatment group and 300 mg/kg/day VPA treatment group.
Clinically, VPA is a widely used AED and is effective to many types of epilepsy (Bazil, 2002) . Previous studies have suggested that VPA at a dose of 250-300 mg/kg/day controls seizures with little memory deficit in rodent models (Jellett, Jenks, Lucas, & Scott, 2015; Mishra & Goel, 2015) . Our study confirms that treatment with VPA at a dose of 300 mg/kg/day significantly reduced seizure severity, cognitive impairment and neuronal cell apoptosis of the hippocampal CA1 region in kindled animals. This was consistent with previous studies (Jellett et al., 2015; Mishra & Goel, 2015) .
The attenuation of elevated acetylcholinesterase activity is involved in the protective mechanisms of VPA against epilepsy associated memory deficit (Mishra & Goel, 2015) . In addition, VPA has been reported to improve neurological deficits through modulating the inflammatory response in a permanent ischemia model with hyperglycemia (Suda, Ueda, Nito, Nishiyama, Okubo, Abe, . . . Kimura, 2015) . Inflammatory response also involves seizures associated hippocampal damage (Legido & Katsetos, 2014; Xiao, Peng, Yang, Kong, & Yin, 2015) . Therefore, we have reason to speculate the immunomodulatory effects of VPA also play a role in the protective mechanisms of VPA against epilepsy-associated memory deficit.
LTG is also a broad-spectrum AED that has been widely used in clinic (Bazil, 2002; Beltramini et al., 2015) . LTG blocks voltage-sensitive sodium channels and consequently inhibits the release of glutamate and aspartate (Beltramini et al., 2015) . Compared to other AEDs, LTG was not found to have significant cognitive impairment effect on healthy adult volunteers (Cohen, Ashby, Crowley, Land, Peck, & Miller, 1985; Meador, Loring, Vahle, Ray, Werz, Fessler, . . . Kustra, 2005) .
Chronic LTG treatment can also reduce comorbid anxiety and depression in the spontaneous absence epilepsy model, suggesting its beneficial effect to LTG treated patients (Huang, Lee, Chen, & Shaw, 2012) .
In this study, we investigated the effect of different doses of LTG through the MWM test. We found that PTZ-kindle-induced learning and memory deficit did not get worse when LTG dose increased, even though neuronal cell apoptosis in the hippocampal CA3 region appeared to be severe in high-dose LTG treated animals. Furthermore, there was no statistical difference compared to the middle-dose LTG group and 300 mg/kg/day VPA treated group.
Previous studies have suggested that LTG decreased seizure severity and hippocampal CA3 region damage in PTZ-kindled animals (Haggag, Hasanin, Raafat, & Abdel, 2014) . Unfortunately, we did not find this reduction in neuronal cell apoptosis in the hippocampal CA3 region both in LTG and VPA treated animals in our study, which is consistent with a study on LTG and VPA in a status epilepticus model of rat pups (Halbsgut, Fahim, Kapoor, Hong, & Friedman, 2013) . The mechanism of neuronal damage induced by epilepsy remains controversial. Higher caspases-3 activity in the hippocampal CA1 and CA3 regions may contribute to neuronal damage (Jafarian, Karimzadeh, Alipour, Attari, Lotfinia, Speckmann, . . . Gorji, 2015) , while caspases-3 activity was not found to be involved in the N-methyl-D-aspartate (NMDA) receptor channel-induced neuronal damage in a PTZ-kindling model (Zaitsev, Kim, Vasilev, Lukomskaya, Lavrentyeva, Tumanova, . . . Magazanik, 2015) . The extent of NMDA-induced cell injury in the CA1 and CA3 regions was different (Ikegaya & Matsuki, 2002; Serpa, Pinto, Bernardino, & Cascalheira, 2015; Vornov, Tasker, & Coyle, 1991) . The CA1 region appeared to be more susceptible to NMDA-induced cytotoxicity in some previous studies (Ikegaya & Matsuki, 2002; Vornov, Tasker, & Coyle, 1991) , while the CA3 region was observed to be more susceptible and only obtained neuroprotective action against NMDAinduced excitotoxicity in a recently study (Serpa, Pinto, Bernardino, & Cascalheira, 2015) . Further studies need to be conducted to determine the mechanism that leads to this spatial distinct in the hippocampus.
In conclusion, our data suggest that LTG may ameliorate epilepsyinduced cognitive impairment and neuronal cell apoptosis during epilepsy treatment.
